+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Heterozygous expression of the oncogenic Pik3ca(H1047R) mutation during murine development results in fatal embryonic and extraembryonic defects

Heterozygous expression of the oncogenic Pik3ca(H1047R) mutation during murine development results in fatal embryonic and extraembryonic defects

Developmental Biology 404(1): 14-26

The phosphoinositide 3-kinase (PI3K)/AKT signalling pathway regulates many cellular functions including proliferation, migration, survival and protein synthesis. Somatic mutations in PIK3CA, the gene encoding the p110α catalytic subunit of PI3K enzyme, are commonly associated with many human cancers as well as recently being implicated in human overgrowth syndromes. However, it is not clear if such mutations can be inherited through the germline. We have used a novel mouse model with Cre recombinase (Cre)-conditional knock-in of the common H1047R mutation into the endogenous Pik3ca gene. Heterozygous expression of the Pik3ca(H1047R) mutation in the developing mouse embryo resulted in failed 'turning' of the embryo and disrupted vascular remodelling within the embryonic and extraembryonic tissues, leading to lethality prior to E10. As vascular endothelial growth factor A (VEGF-A) signalling was disrupted in these embryos, we used Cre under the control of the Tie2 promoter to target the Pik3ca(H1047R) mutation specifically to endothelial cells. In these embryos turning occurred normally but the vascular remodelling defects and embryonic lethality remained, likely as a result of endothelial hyperproliferation. Our results confirm the lethality associated with heterozygous expression of the Pik3ca(H1047R) mutation during development and likely explain the lack of inherited germline PIK3CA mutations in humans.

(PDF emailed within 0-6 h: $19.90)

Accession: 057985539

Download citation: RISBibTeXText

PMID: 25958091

DOI: 10.1016/j.ydbio.2015.04.022

Related references

Physiological expression of the PI3K-activating mutation Pik3ca(H1047R) combines with Apc loss to promote development of invasive intestinal adenocarcinomas in mice. Biochemical Journal 458(2): 251-258, 2014

Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors. Plos One 7(5): E36924-E36924, 2012

Investigating the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant. Plos Computational Biology 10(10): E1003895-E1003895, 2015

PI3K/mTOR Inhibitors in Cancers with PIK3CA H1047R Mutation. 2013

Highly sensitive detection of the PIK3CA (H1047R) mutation in colorectal cancer using a novel PCR-RFLP method. Bmc Cancer 16(): 454-454, 2016

Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin. Oncotarget 4(9): 1484-1495, 2014

PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials. Cancer Research 73(1): 276-284, 2013

Luminal expression of PIK3CA mutant H1047R in the mammary gland induces heterogeneous tumors. Cancer Research 71(13): 4344-4351, 2011

Penetrance of eye defects in mice heterozygous for mutation of Gli3 is enhanced by heterozygous mutation of Pax6. Bmc Developmental Biology 6: 46-46, 2006

Functional differences between two classes of oncogenic mutation in the PIK3CA gene. Biochemical and Biophysical Research Communications 381(4): 577-581, 2009

DW09849, a selective phosphatidylinositol 3-kinase (PI3K) inhibitor, prevents PI3K signaling and preferentially inhibits proliferation of cells containing the oncogenic mutation p110α (H1047R). Journal of Pharmacology and Experimental Therapeutics 348(3): 432-441, 2014

Overexpression of COUP-TF1 in murine embryonic stem cells reduces retinoic acid-associated growth arrest and increases extraembryonic endoderm gene expression. Differentiation; Research in Biological Diversity 76(7): 760-771, 2008

Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma. Biomed Research International 2014: 810487-810487, 2014

Gene expression patterns in heterozygous Plk4 murine embryonic fibroblasts. Bmc Genomics 10(): 319-319, 2009

Protein synthesis and gene expression in embryonic and extraembryonic tissues of the mouse during postimplantation development. Biological Chemistry Hoppe-Seyler 374(9): 783, 1993